ReachRxResearch
Home
Research
Sign Up
A Case Report of a Novel LTBP4 Variant in Urban‐Rifkin‐Davis Syndrome Presenting With Lobar Overinflation in an Adolescent Girl
Back to Research Hub
  1. Home
  2. Research Hub
  3. A Case Report of a Novel LTBP4 Variant i…

A Case Report of a Novel LTBP4 Variant in Urban‐Rifkin‐Davis Syndrome Presenting With Lobar Overinflation in an Adolescent Girl

Pediatric Pulmonology·August 5Open Access
Respiratory SystemLimited evidenceAtrial Septal DefectCongenital Diaphragmatic HerniaCutis Laxa Type 1CEisenmenger SyndromeLobar OverinflationPulmonary HypertensionUrban-Rifkin-Davis SyndromeCase ReportSurgical LobectomyAdolescent

Summary

View source

What was studied

A case report of a 14-year-old girl with Urban-Rifkin-Davis Syndrome (URDS; autosomal recessive cutis laxa type 1C) carrying a novel LTBP4 frameshift variant (c.3512dup, p.Arg1172ProfsTer60), presenting with left upper lobar overinflation, diaphragmatic hernia, ASD with Eisenmenger physiology, and severe pulmonary hypertension.

Key findings

Left upper lobectomy improved oxygen saturation from 75% to 85%; whole exome sequencing identified a novel likely pathogenic LTBP4 variant not previously reported, in a patient who survived into adolescence despite a reported mean URDS survival of ~4 years.

Study limitations

Single case report limits generalizability; no long-term follow-up data reported post-discharge; causality between the novel variant and specific phenotypic features cannot be fully established without functional studies.

Clinical implications

In a child with lobar overinflation, loose/sagging skin, facial dysmorphism, and multi-system anomalies, consider URDS and pursue whole exome sequencing early. Comprehensive workup should include echocardiography, GI evaluation, and diaphragmatic imaging, as respiratory and cardiac complications can be severe and partially reversible with surgical intervention.

Caveats

  • Mean survival of 4 years cited for URDS comes from prior literature, not this study; this case represents an outlier with delayed presentation.
  • The novel LTBP4 variant is classified as 'likely pathogenic' per ACMG criteria but lacks functional validation in this paper.
  • This is a single case report (n=1); findings are not generalizable and no control or comparative data are available.

Related Questions

Explore related topics

What are the typical respiratory and cardiac findings in Urban-Rifkin-Davis Syndrome (LTBP4 mutations)?How should clinicians work up a child with lobar overinflation and connective tissue features?What is the prognosis and management of Eisenmenger syndrome in pediatric connective tissue disorders?

Publication Details

Year
2026
Journal
Pediatric Pulmonology
Sample Size
n=1
Source
View article
Keep scrolling
More content below.
Up Next